Lupkynis (voclosporin) - Aurinia Pharma
Safety and efficacy of adding voclosporin to standard treatment of lupus nephritis in adult patients: a meta-analysis and time-to-event analysis of randomized controlled trials. (PubMed, Int Urol Nephrol) - Apr 2, 2026 - "This analysis highlights the superior efficacy outcomes of voclosporin in inducing LN remission and reducing proteinuria. However, the risk of adverse effects was higher when voclosporin was used. Larger primary studies are needed to explore its exact safety profile." 
Journal • Retrospective data • Review • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/41922881
 
Hasan Naeem Kareem; Hebatullah Abdulazeem; Lava Abdullah; Marym Taha Abdelhamid; Mohamed R Murad; Mohamed Saad Sayed; Saadya Hadi Humade; Zineddine Belabaci
 
Apr 2, 2026
 
Prev Next